# Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)

> **NCT01079182** · — · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 4681 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01079182
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 4681 (ACTUAL)
- **Last updated:** 2015-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01079182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01079182, "Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01079182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*